Ming Lu

University of Science and Technology of China — China

Medicine · Health Sciences

22h-index2.3kcitations175works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(89), HER2/EGFR in Cancer Research(51), Glycosylation and Glycoproteins Research(29), Radiopharmaceutical Chemistry and Applications(25), Cancer Research and Treatments(25)

Publications175 total

Figure S2 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
2025Open Access
Figure S8 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
2025Open Access
Figure S5 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
2025Open Access
Figure S4 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
2025Open Access
Figure S7 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
2025Open Access
Figure S6 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
2025Open Access
Figure S3 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
2025Open Access
Figure S1 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
2025Open Access
Supplemental Methods 1 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
2025Open Access
Supplemental Tables 1 from Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors
2025Open Access
Mn4Al11: A Half-Semimetal Candidate with Anomalous Electronic Behaviors
arXiv (Cornell University)·2025Open Access
Predicting 177Lu-DOTATATE therapy response through immune microenvironment parameters in gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
European Journal of Nuclear Medicine and Molecular Imaging·2025· 1 cited
Mn<sub>4</sub>Al<sub>11</sub>: A Half-Semimetal Candidate with Anomalous Electronic Behaviors
Chinese Physics Letters·2025
Long-distance transmission of tmexCD1-toprJ1 positive Klebsiella pneumoniae between humans and food animals
International Journal of Antimicrobial Agents·2025· 1 cited
Rapamycin-induced small extracellular vesicles under GelMA scaffolds facilitate diabetic wound repair through accelerating angiogenesis and alleviating macrophage-mediated inflammation via PI3K/Akt signaling pathway
Materials Today Bio·2025· 1 citedOpen Access
DTGHAT: multi-molecule heterogeneous graph transformer based on multi-molecule graph for drug-target identification
Frontiers in Pharmacology·2025· 2 citedOpen Access
Distinct role of virulence and antimicrobial resistance on mortality within a large Klebsiella spp. cohort
2025Open Access
Long-Term Safety and Efficacy of Oral Deucrictibant for Treatment of Hereditary Angioedema Attacks: Results of the RAPIDe-2 Extension Study
Journal of Allergy and Clinical Immunology·2025Open Access
Overexpression of <i>bla</i> <sub>SHV-12</sub> caused by tandem amplification contributed to ceftazidime/avibactam resistance in hypervirulent and carbapenem-resistant <i>Klebsiella pneumoniae</i>
Emerging Microbes & Infections·2024· 3 citedOpen Access
Abietic Acid Alleviates the Hypoxic Injury of Cardiomyocytes by Adjusting Autophagy and Apoptosis Mediated by miR-30a-5p/GRP78 Axis.
PubMed·2024· 2 cited
page 1 of 9Next →

Frequent Co-authors

Xin Qiao(10), Weihui Zhang(10), Dongbo Xue(10), Chao Liu(10), Ning Shen(10), Juan Yi(8), Ping Yang(8), Bei Sun(7), Pengcheng Du(7), Dennis J. Slamon(6), Bo Gao(6), Andrew J. Norris(4), Maryam Sartippour(4), Mai N. Brooks(4), Julian P. Whitelegge(4), Kevin Chau(4), Neil A. O’Brien(4), Benjamin Hoffstrom(4), KeWei Gong(4), Tong Luo(4)